Ironwood Pharmaceuticals (IRWD) News Today → Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share (From Colonial Metals) (Ad) Free IRWD Stock Alerts $7.82 -0.26 (-3.22%) (As of 04/26/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineIronwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Receives Average Rating of "Buy" from Brokeragesamericanbankingnews.com - April 26 at 3:08 AMIronwood Pharmaceuticals to Host First Quarter 2024 Investor Update Callbusinesswire.com - April 25 at 4:01 PM5 Best Low Price Pharma Stocks To Invest Ininsidermonkey.com - April 22 at 11:14 AMGuru Fundamental Report for IRWDnasdaq.com - April 20 at 10:27 AMIronwood Pharmaceuticals (NASDAQ:IRWD) Reaches New 52-Week Low at $7.78marketbeat.com - April 15 at 2:48 PMIronwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Short Interest Updatemarketbeat.com - April 14 at 7:21 PMIronwood Pharmaceuticals (NASDAQ:IRWD) Trading Down 2.9%marketbeat.com - April 8 at 2:28 PMIronwood Pharmaceuticals (NASDAQ:IRWD) Sets New 52-Week Low at $8.07marketbeat.com - April 3 at 5:31 PMPiper Sandler Reaffirms Their Buy Rating on Ironwood Pharma (IRWD)markets.businessinsider.com - April 1 at 2:01 PMIronwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Receives Average Rating of "Buy" from Analystsmarketbeat.com - April 1 at 4:14 AMIronwood Pharmaceuticals (NASDAQ:IRWD) Upgraded to "Buy" by StockNews.commarketbeat.com - March 29 at 11:15 PMAnalysts Are Bullish on Top Healthcare Stocks: Mediwound (MDWD), Ironwood Pharma (IRWD)markets.businessinsider.com - March 28 at 11:02 PMIronwood Pharmaceuticals Announces Positive Results from its Phase II Exploratory STARGAZE Trial of Apraglutide in Patients with Steroid-Refractory Gastrointestinal Acute Graft-versus-Host Disease (SR GI aGVHD)businesswire.com - March 28 at 7:30 AMEquities Analysts Set Expectations for Ironwood Pharmaceuticals, Inc.'s FY2024 Earnings (NASDAQ:IRWD)marketbeat.com - March 22 at 8:19 AMResearch Analysts Offer Predictions for Ironwood Pharmaceuticals, Inc.'s Q4 2024 Earnings (NASDAQ:IRWD)marketbeat.com - March 21 at 8:06 AMValidea Detailed Fundamental Analysis - IRWDnasdaq.com - March 20 at 4:29 PMWalleye Capital LLC Purchases Shares of 166,968 Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD)marketbeat.com - March 19 at 4:21 AMIronwood Pharmaceuticals (NASDAQ:IRWD): Analysts Stay Bullish Despite Recent Stock Plungemsn.com - March 16 at 3:50 PMInsider Buying: Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) CFO Acquires 10,684 Shares of Stockinsidertrades.com - March 16 at 10:15 AMIt’s Time! 3 Failing Biotech Stocks to Sell Right Nowfinance.yahoo.com - March 13 at 2:01 AM2,378,295 Shares in Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Purchased by Jacobs Levy Equity Management Inc.marketbeat.com - March 12 at 8:38 AMIronwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Director Purchases $60,204.00 in Stockinsidertrades.com - March 11 at 7:38 AMQ1 2025 EPS Estimates for Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Cut by Zacks Researchmarketbeat.com - March 11 at 2:50 AMAdage Capital Partners GP L.L.C. Boosts Stock Holdings in Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD)marketbeat.com - March 7 at 7:44 AMIronwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Given Average Recommendation of "Buy" by Analystsmarketbeat.com - March 7 at 5:47 AMIronwood Pharmaceuticals, Inc. (NASDAQ:IRWD) to Post Q1 2024 Earnings of $0.18 Per Share, Zacks Research Forecastsmarketbeat.com - March 6 at 7:32 AMIt's Time! 3 Failing Biotech Stocks to Sell Right Nowinvestorplace.com - March 5 at 1:05 PMGlenmede Trust Co. NA Raises Position in Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD)marketbeat.com - March 4 at 9:28 AMIRWD Mar 2024 5.000 putfinance.yahoo.com - March 3 at 6:15 PMIronwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Shares Sold by 13D Management LLCmarketbeat.com - March 3 at 12:28 PMIronwood plunges nearly 40% after SBS trial misses secondary goalsmsn.com - March 1 at 4:09 PMIronwood's bowel disease drug meets main goal of late-stage studyreuters.com - March 1 at 4:09 PMWells Fargo & Company Trims Ironwood Pharmaceuticals (NASDAQ:IRWD) Target Price to $14.00marketbeat.com - March 1 at 1:41 PMIronwood Pharmaceuticals (NASDAQ:IRWD) Trading Down 5.7%marketbeat.com - March 1 at 12:15 PMIronwood Pharmaceuticals: Strong Buy Rating on LINZESS Performance and Apraglutide Market Potentialmarkets.businessinsider.com - February 29 at 11:53 PMIronwood Pharmaceuticals Ran Up 32% Over Two Months — And Just Lost It Allfinance.yahoo.com - February 29 at 1:52 PMIronwood says bowel disease treatment meets main goal in late-stage trialreuters.com - February 29 at 8:52 AMIronwood Pharma: Apraglutide Trial Meets Primary Goal, But Some Secondary Goals Not Met; Stock Dipsmarkets.businessinsider.com - February 29 at 8:52 AMWhy Is Ironwood Pharmaceuticals (IRWD) Stock Down 27% Today?msn.com - February 29 at 8:52 AMIronwood Pharmaceuticals Announces Positive Topline Results from Global Phase III Trial of Once-Weekly Apraglutide in Adults with Short Bowel Syndrome with Intestinal Failure (SBS-IF)finance.yahoo.com - February 29 at 8:52 AMCharles Schwab Investment Management Inc. Has $11.85 Million Position in Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD)marketbeat.com - February 28 at 4:25 AMAnalysts Offer Insights on Healthcare Companies: Blueprint Medicines (BPMC), AMN Healthcare Services (AMN) and Ironwood Pharma (IRWD)markets.businessinsider.com - February 26 at 8:07 AMIronwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Shares Purchased by UBS Group AGmarketbeat.com - February 24 at 4:34 AMIronwood Pharmaceuticals to Present Four Abstracts at the ASPEN 2024 Nutrition Science & Practice Conferencebusinesswire.com - February 23 at 7:30 AMIronwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Shares Sold by Commonwealth of Pennsylvania Public School Empls Retrmt SYSmarketbeat.com - February 22 at 5:16 AMQRG Capital Management Inc. Makes New Investment in Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD)marketbeat.com - February 20 at 7:04 AMIronwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Shares Sold by Quantedge Capital Pte Ltdmarketbeat.com - February 19 at 10:27 AMCapital One Financial Weighs in on Ironwood Pharmaceuticals, Inc.'s FY2025 Earnings (NASDAQ:IRWD)marketbeat.com - February 19 at 3:27 AMRafferty Asset Management LLC Has $8.42 Million Stake in Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD)marketbeat.com - February 18 at 7:28 AMIronwood Pharmaceuticals Full Year 2023 Earnings: EPS Misses Expectationsfinance.yahoo.com - February 17 at 10:39 AM Get Ironwood Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for IRWD and its competitors with MarketBeat's FREE daily newsletter. Email Address This AI Trade Machine Made 1,729%* (With 89% Wins) (Ad)This A.I. trading software called out an options trade the other day with a nearly perfect historical win rate… And a cumulative gain of 1729%. How does it all work? Click Here To Get Your Free Copy IRWD Media Mentions By Week IRWD Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. IRWD News Sentiment▼0.570.32▲Average Medical News Sentiment IRWD News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. IRWD Articles This Week▼33▲IRWD Articles Average Week Get Ironwood Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for IRWD and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: MannKind News Ligand Pharmaceuticals News Dynavax Technologies News Innoviva News OPKO Health News Cryoport News IGM Biosciences News Geron News Lexicon Pharmaceuticals News Amicus Therapeutics News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:IRWD) was last updated on 4/27/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThey say it’s ‘unstoppable’ – How I made 43,509% Investing DailyThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyProtect Your Bank Account Before It’s Too LateWeiss RatingsDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithJeff Bezos Just Humiliated Elon MuskInvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ironwood Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
